Predicting Mortality and Cirrhosis-Related Complications with MELD3.0: A Multicenter Cohort Analysis

Area of Science:

• Hepatology
• Clinical prediction models
• Liver disease prognosis

Background:

• Cirrhosis patient outcomes require accurate prognostic tools.
• Existing models like Child-Pugh, MELD, and MELDNa have limitations.
• The Model for End-Stage Liver Disease (MELD) 3.0 is a newer scoring system.

Purpose of the Study:

• To evaluate the predictive performance of MELD 3.0.
• To compare MELD 3.0 against Child-Pugh, ALBI grade, MELD, and MELDNa.
• To assess MELD 3.0's association with cirrhosis-related complications.

Main Methods:

• Retrospective analysis of 3,314 cirrhosis patients (2013-2019).
• Comparison of Area Under the Receiver Operating Characteristic Curve (AUROC) for 3-month mortality.
• Assessment of cirrhosis-related complication risks based on MELD 3.0 scores.

Main Results:

• MELD 3.0 achieved the highest AUROC (0.851) for predicting 3-month mortality.
• Higher MELD 3.0 scores significantly correlated with increased mortality risk.
• MELD 3.0 score increases were linked to higher risks of hepatorenal syndrome, hepatic encephalopathy, and ascites.

Conclusions:

• MELD 3.0 demonstrates superior prognostic accuracy for cirrhosis mortality.
• MELD 3.0 effectively predicts various cirrhosis-related complications, especially kidney-related issues.
• MELD 3.0 shows promise as an improved clinical prediction tool for liver disease.